Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 9.10% is 191% above its 5-year average of -9.98%, near the high end of its 5-year range (-37.92%–19.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.83% below its 12-month average of 10.69%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
9.10%
RETURN ON EQUITY (ROE) AVG TTM
10.69%
RETURN ON EQUITY (ROE) AVG 3Y
-7.61%
RETURN ON EQUITY (ROE) AVG 5Y
-9.98%
RETURN ON EQUITY (ROE) AVG 10Y
-15.07%
RETURN ON EQUITY (ROE) AVG 15Y
-6.78%
RETURN ON EQUITY (ROE) AVG 20Y
-1.00%
CURRENT VS TTM AVG
-14.83%
CURRENT VS 3Y AVG
+219.54%
CURRENT VS 5Y AVG
+191.20%
CURRENT VS 10Y AVG
+160.39%
CURRENT VS 15Y AVG
+234.18%
CURRENT VS 20Y AVG
+1006.21%
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-20.44%
vs the sector median at left
Teva Pharmaceutical Industries Limited
Market Cap
$42.82B
Return on Equity (ROE)
9.10%
TTM Avg
10.69%
3Y Avg
-7.61%
5Y Avg
-9.98%
Market Cap
$43.10B
Return on Equity (ROE)
22.28%
TTM Avg
21.77%
3Y Avg
21.17%
5Y Avg
17.55%
Market Cap
$43.39B
Return on Equity (ROE)
19.56%
TTM Avg
20.59%
3Y Avg
21.51%
5Y Avg
20.54%
Market Cap
$43.62B
Return on Equity (ROE)
70.67%
TTM Avg
60.82%
3Y Avg
72.53%
5Y Avg
81.69%
Market Cap
$46.95B
Return on Equity (ROE)
6.65%
TTM Avg
7.05%
3Y Avg
11.93%
5Y Avg
15.09%
Market Cap
$34.73B
Return on Equity (ROE)
23.13%
TTM Avg
23.30%
3Y Avg
22.33%
5Y Avg
21.49%
Market Cap
$34.14B
Return on Equity (ROE)
38.14%
TTM Avg
28.93%
3Y Avg
25.01%
5Y Avg
22.95%
Market Cap
$51.97B
Return on Equity (ROE)
9.46%
TTM Avg
26.07%
3Y Avg
24.86%
5Y Avg
23.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | $42.82B | 9.10% | 10.69% | -7.61% | -9.98% |
| IQVIA Holdings Inc. (IQV)vs › | $43.10B | 22.28% | 21.77% | 21.17% | 17.55% |
| Agilent Technologies, Inc. (A)vs › | $43.39B | 19.56% | 20.59% | 21.51% | 20.54% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.62B | 70.67% | 60.82% | 72.53% | 81.69% |
| Humana Inc. (HUM)vs › | $46.95B | 6.65% | 7.05% | 11.93% | 15.09% |
| Alcon Inc. (ALC)vs › | $34.95B | 2.96% | 4.58% | 3.90% | 2.45% |
| ResMed Inc. (RMD)vs › | $34.73B | 23.13% | 23.30% | 22.33% | 21.49% |
| DexCom, Inc. (DXCM)vs › | $34.14B | 38.14% | 28.93% | 25.01% | 22.95% |
| Edwards Lifesciences Corporation (EW)vs › | $51.97B | 9.46% | 26.07% | 24.86% | 23.86% |
| Becton, Dickinson and Company (BDX)vs › | $52.22B | 3.85% | 6.60% | 6.50% | 6.42% |
ROE
9.1%
ROA
1.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 9.10% |
| 2026-03-31 | 19.01% |
| 2025-12-31 | 17.81% |
| 2025-09-30 | 9.82% |
| 2025-06-30 | -2.31% |
| 2025-03-31 | -20.54% |
| 2024-12-31 | -30.50% |
| 2024-09-30 | -15.81% |
| 2024-06-30 | -7.12% |
| 2024-03-31 | -6.58% |
| 2023-12-31 | -7.46% |
| 2023-09-30 | -32.39% |
| 2023-06-30 | -32.01% |
| 2023-03-31 | -20.57% |
| 2022-12-31 | -30.14% |
| 2022-09-30 | -14.71% |
| 2022-06-30 | -11.66% |
| 2022-03-31 | -6.58% |
| 2021-12-31 | 4.06% |
| 2021-09-30 | 6.94% |
| 2021-06-30 | -37.92% |
| 2021-03-31 | -39.82% |
| 2020-12-31 | -39.80% |
| 2020-09-30 | -42.02% |
| 2020-06-30 | 0.03% |
| 2020-03-31 | -6.10% |
| 2019-12-31 | -7.15% |
| 2019-09-30 | -28.96% |
| 2019-06-30 | -27.53% |
| 2019-03-31 | -22.91% |
| 2018-12-31 | -15.06% |
| 2018-09-30 | -61.27% |
| 2018-06-30 | -56.45% |
| 2018-03-31 | -85.49% |
| 2017-12-31 | -94.45% |
| 2017-09-30 | -20.34% |
| 2017-06-30 | -21.49% |
| 2017-03-31 | 0.61% |
| 2016-12-31 | 0.60% |
| 2016-09-30 | 4.76% |
| 2016-06-30 | 4.73% |
| 2016-03-31 | 5.63% |
| 2015-12-31 | 5.33% |
| 2015-09-30 | 7.81% |
| 2015-06-30 | 11.06% |
| 2015-03-31 | 12.18% |
| 2014-12-31 | 13.10% |
| 2014-09-30 | 11.63% |
| 2014-06-30 | 10.97% |
| 2014-03-31 | 6.02% |
| 2013-12-31 | 5.62% |
| 2013-09-30 | 5.42% |
| 2013-06-30 | 1.95% |
| 2013-03-31 | 7.63% |
| 2012-12-31 | 8.62% |
| 2012-09-30 | 9.37% |
| 2012-06-30 | 13.82% |
| 2012-03-31 | 12.39% |
| 2011-12-31 | 12.43% |
| 2011-09-30 | 13.23% |
| 2011-06-30 | 13.33% |
| 2011-03-31 | 14.64% |
| 2010-12-31 | 15.18% |
| 2010-09-30 | 13.56% |
| 2010-06-30 | 13.13% |
| 2010-03-31 | 11.51% |
| 2009-12-31 | 10.40% |
| 2009-09-30 | 4.84% |
| 2009-06-30 | 5.17% |
| 2009-03-31 | 5.82% |
| 2008-12-31 | 3.90% |
| 2008-09-30 | 12.75% |
| 2008-06-30 | 11.81% |
| 2008-03-31 | 12.20% |
| 2007-12-31 | 14.22% |
| 2007-09-30 | 14.26% |
| 2007-06-30 | 15.95% |
| 2007-03-31 | 16.66% |
| 2006-12-31 | 4.90% |
| 2006-09-30 | 3.70% |
| 2006-06-30 | 0.52% |
| 2006-03-31 | -2.12% |
| 2005-12-31 | 17.75% |
| 2005-09-30 | 18.79% |
| 2005-06-30 | 19.41% |
| 2005-03-31 | 19.23% |
| 2004-12-31 | 6.16% |
| 2004-09-30 | 4.69% |
| 2004-06-30 | 3.20% |
| 2004-03-31 | 2.92% |
| 2003-12-31 | 21.01% |
| 2003-09-30 | 26.85% |
| 2003-06-30 | 26.34% |
